BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

672 related articles for article (PubMed ID: 24272889)

  • 1. Cancer multidrug resistance: mechanisms involved and strategies for circumvention using a drug delivery system.
    Kibria G; Hatakeyama H; Harashima H
    Arch Pharm Res; 2014 Jan; 37(1):4-15. PubMed ID: 24272889
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of integrated cancer nanomedicine in overcoming drug resistance.
    Iyer AK; Singh A; Ganta S; Amiji MM
    Adv Drug Deliv Rev; 2013 Nov; 65(13-14):1784-802. PubMed ID: 23880506
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy.
    Pérez-Herrero E; Fernández-Medarde A
    Eur J Pharm Biopharm; 2015 Jun; 93():52-79. PubMed ID: 25813885
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reversal of multidrug resistance by stimuli-responsive drug delivery systems for therapy of tumor.
    Yin Q; Shen J; Zhang Z; Yu H; Li Y
    Adv Drug Deliv Rev; 2013 Nov; 65(13-14):1699-715. PubMed ID: 23611952
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nanomedicine for targeted cancer therapy: towards the overcoming of drug resistance.
    Shapira A; Livney YD; Broxterman HJ; Assaraf YG
    Drug Resist Updat; 2011 Jun; 14(3):150-63. PubMed ID: 21330184
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nanoparticle approaches to combating drug resistance.
    Moon JH; Moxley JW; Zhang P; Cui H
    Future Med Chem; 2015 Aug; 7(12):1503-10. PubMed ID: 26334205
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Carbon-based drug delivery carriers for cancer therapy.
    Lim DJ; Sim M; Oh L; Lim K; Park H
    Arch Pharm Res; 2014 Jan; 37(1):43-52. PubMed ID: 24234911
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Progress in the study of micelle delivery system reversing multidrug resistance].
    Diao YY; Han M; Chen DW; Gao JQ
    Yao Xue Xue Bao; 2009 Jul; 44(7):710-5. PubMed ID: 19806907
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nanoscale drug delivery for targeted chemotherapy.
    Xin Y; Huang Q; Tang JQ; Hou XY; Zhang P; Zhang LZ; Jiang G
    Cancer Lett; 2016 Aug; 379(1):24-31. PubMed ID: 27235607
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Progress in the study of drug delivery system based on nanoparticles to overcome multi-drug resistance].
    Chen JN; Shen Q; Li SS
    Yao Xue Xue Bao; 2009 Apr; 44(4):333-7. PubMed ID: 19545047
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nanomaterial-induced autophagy: a new reversal MDR tool in cancer therapy?
    Panzarini E; Dini L
    Mol Pharm; 2014 Aug; 11(8):2527-38. PubMed ID: 24921216
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Particle carriers for combating multidrug-resistant cancer.
    Yan Y; Björnmalm M; Caruso F
    ACS Nano; 2013 Nov; 7(11):9512-7. PubMed ID: 24215340
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Engineering Nanomedicines to Overcome Multidrug Resistance in Cancer Therapy.
    Beretta GL; Cavalieri F
    Curr Med Chem; 2016; 23(1):3-22. PubMed ID: 26438248
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Different strategies to overcome multidrug resistance in cancer.
    Saraswathy M; Gong S
    Biotechnol Adv; 2013 Dec; 31(8):1397-407. PubMed ID: 23800690
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nanomedicine: An effective tool in cancer therapy.
    Aftab S; Shah A; Nadhman A; Kurbanoglu S; Aysıl Ozkan S; Dionysiou DD; Shukla SS; Aminabhavi TM
    Int J Pharm; 2018 Apr; 540(1-2):132-149. PubMed ID: 29427746
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanisms of chemotherapeutic drug resistance in cancer therapy--a quick review.
    Liu FS
    Taiwan J Obstet Gynecol; 2009 Sep; 48(3):239-44. PubMed ID: 19797012
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Extracellular stability of nanoparticulate drug carriers.
    Liu KC; Yeo Y
    Arch Pharm Res; 2014 Jan; 37(1):16-23. PubMed ID: 24214175
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeted nanomedicine for cancer therapeutics: Towards precision medicine overcoming drug resistance.
    Bar-Zeev M; Livney YD; Assaraf YG
    Drug Resist Updat; 2017 Mar; 31():15-30. PubMed ID: 28867241
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Liposomes and nanoparticles: nanosized vehicles for drug delivery in cancer.
    Malam Y; Loizidou M; Seifalian AM
    Trends Pharmacol Sci; 2009 Nov; 30(11):592-9. PubMed ID: 19837467
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gold nanoparticle (AuNP)-based drug delivery and molecular imaging for biomedical applications.
    Jeong EH; Jung G; Hong CA; Lee H
    Arch Pharm Res; 2014 Jan; 37(1):53-9. PubMed ID: 24214174
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 34.